ASX (AUD): Fisher & Paykel Healthcare Corporation Limited (FPH)
Last Price
25.22
Today's Change
-0.23 (0.90%)
Day's Change
24.95 - 25.78
Trading Volume
233,514
Market Cap
14 Billion
Shares Outstanding
583 Million
Avg Volume
297,570
Avg Price (50 Days)
23.42
Avg Price (200 Days)
21.73
PE Ratio
61.51
EPS
0.41
Earnings Announcement
28-May-2024
Previous Close
25.45
Open
25.73
Day's Range
24.95 - 25.78
Year Range
18.58 - 26.08
Trading Volume
233,514
1 Day Change
-0.90%
5 Day Change
2.94%
1 Month Change
6.59%
3 Month Change
14.95%
6 Month Change
33.58%
Ytd Change
14.38%
1 Year Change
-1.60%
3 Year Change
-24.24%
5 Year Change
68.92%
10 Year Change
589.07%
Max Change
937.86%
No result.
Sector: Healthcare - Healthcare
Industry: Medical Instruments & Supplies
Description:
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.